Treatment of HER2 positive cancers | Patent Number 11666572

US 11666572 B2
Application Number17530265
Publication NumberUS 20220168303 A1
Pendency1 year, 6 months, 20 days
Filled DateNov 18, 2021
Priority DateApr 28, 2017
Publication DateJun 2, 2022
Expiration DateApr 27, 2037
Inventor/ApplicantsLuke Walker
Scott Peterson
ExaminesSEAMAN, D MARGARET M
Art Unit1625
Technology Center1600
Assignments
Seagen Inc.
Current
Seagen Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.